The Meta Quest 3 is a major improvement over the Quest 2. It is just superior in every way: more cozy, more potent, simpler to understand, more enjoyable to use for extended periods of time, etc. That settles all of your questions about the newest headset from Meta. Even if you bought a Quest 2 only a few years ago and may not have used it as much as you thought you may, the passthrough improvements alone make this an upgrade that is beneficial. The hardware in Quest 3 is remarkable and significantly better than it was in Quests 1 and 2.

The Quest 3 is sometimes referred to in Meta as "the first mainstream mixed reality headset." The Quest 2 starts at $299.99. However, at $499.99 for the 128GB device and $649.99 for the 512GB variant, it is still on the right side of the too-expensive line, especially when compared to Apple's upcoming $3,500 Vision Pro. And unlike the mixed reality products from Magic Leap, Microsoft, and many others, this one is genuinely available for individual purchase by consumers. However, Meta would really like for this to be more than just the greatest affordable headset. It wants the Quest 3 to be the one that significantly increases interest in, use of, and development for mixed reality.

Additionally, Meta reduced the size of its Touch Plus controllers by eliminating the sensor rings that made the earlier model bulky and occasionally difficult to store. The manufacturer claims that the improved sensors on the headgear plus some AI/machine-learning upgrades that can better predict your hand and finger movements are what allowed it to do this.

Related: Zotac VR GO 4.0: Backpack PC for Mobile VR

The haptics in the new controllers are substantially more realistic, in addition to being much more convenient. In other circumstances, they feel substantial and tactile, giving me comforting feedback when I push a virtual button or charge a blaster. However, sometimes they can still feel like old Nokia phones buzzing when games trigger the most basic vibrations.

More sensors and cameras

The two new RGB cameras and depth projector might make it obvious that the Quest 3 is designed for mixed reality experiences if Meta's marketing didn't already. With the new headset, you can more accurately reproduce your surroundings in full color and measure how close and far away objects are, reports ZDNet.

Professional-looking pancake lenses Users will be happy to discover that the 4K+ Infinity Display pancake lenses seen on Meta's more costly VR headset are now present on the Quest 3, and for almost a third of what the Quest Pro originally went for. This greatly enhances the sharpness and detail of text and images while also widening your field of vision (FOV), or how much of the screen you can see from one corner to the other. A new Qualcomm Snapdragon XR2 Gen 2 platform, which promises to deliver 2x better graphics performance than the Quest 2, powers the displays and the overall system.

Blucap, the pioneering smart eyewear brand, developed the Blucap Moto navigation sunglasses, creating a new way of navigation and riding experience for motorcycle enthusiasts.

A Revolutionary Motorcycle Navigation

Blucap Moto is a navigation device that displays information directly in front of the rider's line of sight. It offers a distraction-free experience, with turn arrows that only appear when needed. In the name of navigation glasses, Blucap Moto stands out for its map navigation, which can be controlled with a handlebar remote, meeting all your navigation needs in complex road conditions.

In addition, Blucap Moto connects to phones via Bluetooth, eliminating the need to keep the phone screen on when using its navigation features. Riders can choose to keep their phones in a bag or pocket, avoiding the inconvenience of mounting the phone on a holder and potential issues like camera lens vibration damage, rain damage, phone overheating, and battery consumption.

Related: CardoSystems-509 to Transform Motorcycle Helmets

With Blucap Moto, riders can ride safely and without distractions, enjoying an immersive riding experience without the need to look down at their phones.

A tiny MicroLED display then projects a directional arrow onto the inside of the right-hand lens whenever the user comes to an intersection where they must turn. Once the turn has been made, that arrow immediately vanishes.

Pushing a button on the remote temporarily displays a monochrome map segment with the user's position marked on it so they can see where they are on a street map. Incoming calls, text messages, and speed limit notifications can all be displayed on the app. A linked Bluetooth headset from a third party can be used to answer the calls, reports New Atlas.

Having said that, the Motos are made to be incredibly straightforward and uncluttered. They have no buttons or other physical controls, and when their arms are opened, they automatically turn on and link to the phone or remote. According to reports, its internal lithium battery can last for 10 hours of use on a single charge, while a pair of button cell batteries should power the remote for roughly six months.

A neutral pair of fixed inner lenses is included in the eyewear, which can be combined with a variety of adjustable outer lenses. They include a set of tinted, anti-fog, polarized, scratch-resistant outer lenses that completely block UVA and UVB rays. And certainly, prescription lenses may be obtained with them.

Price and Availability

A set of the Blucap Moto sunglasses may be yours for $299 on Kickstarter, provided that the project is successful in moving through with production. Their $399 suggested retail price has been set.

Cardo Systems, a global market leader in wireless communication systems for power sports, has joined forces with leading power sports apparel brand 509 to introduce the Mach V Commander, a groundbreaking motorcycle helmet that transcends the conventional. The Mach V Commander features a fully integrated state-of-the-art Cardo communications system with in-helmet audio and microphone enabling seamless communication and connectivity for you and up to 14 users. The helmet also boasts the industry's leading JBL sound quality and noise cancellation capabilities.

This innovative collaboration catapults 509 into the heart of the motorcycle community, as the Mach V Commander helmet sets a new standard for communication and connectivity on the open road. Marrying 509's acclaimed craftsmanship with Cardo Systems' cutting-edge communication technology, riders can effortlessly converse with fellow riders, manage calls, and enjoy music while on the move.

“As the vanguard of power sports communication, we're thrilled to collaborate with 509 to help enhance motorcyclists' safety and offer a fully integrated communication system to help make the riding experience even better," said Shachar Harari, VP, of Business Development & OEM at Cardo Systems. "This partnership presents a phenomenal opportunity to deliver best-in-class communication coupled with the renowned craftsmanship that both our brands are known for."

Designed to be more than just a piece of protective gear,  the Mach V Commander helmet by 509 represents a leap forward in motorcycle helmet technology. With the ability to effortlessly connect to 15 riders within a range of one mile, the Mach V Commander redefines communication on the open road. Its integrated Cardo System ensures crystal-clear audio quality, allowing riders to communicate with exceptional clarity amidst the ever-changing environments of the open road. Safety and comfort are paramount, with features like an impact-resistant visor, controllable chase light, and advanced moisture control contributing to an enhanced riding experience.

Related: Lockheed Martin to Use Red 6’s AR-Powered Helmet

"We are elated to unveil the Mach V Commander helmet, featuring integrated Cardo Systems, to the vibrant street rider community," said Bill Hartlieb, Global Product Director at 509."Through our collaboration with Cardo Systems, we created a product that authentically elevates connectivity, convenience, and safety on the road."

Innovation, safety, and seamless communication converge in the Mach V Commander helmet with integrated Cardo Systems. Designed for the modern motorcyclist, this collaboration between Cardo Systems and 509 sets a new standard in helmet technology. Discover the future of motorcycle helmets with the Mach V Commander by Cardo Systems and 509.

Key Features of the Mach V Commander Helmet with Cardo Communication System:

·       Group Communication: With Cardo Communication System, riders can stay connected with up to 14 fellow riders within a range of up to 1 mile (1.6 kilometers) through mesh connectivity or connect via Bluetooth® for music, phone, or map capabilities.

·       Superior Audio Quality: The integrated Cardo Communication System ensures crystal-clear sound, with JBL speakers and PSI (Pressurized Sound Isolation) earmuff system for isolation, passive noise canceling, and custom fit.

·       Voice Command and Hands-Free Operation: Riders can keep their hands on the handlebars and their focus on the road, as the Mach V Commander Helmet supports voice commands for seamless operation, making communication effortless and intuitive.

·       Enhanced Safety and Comfort: The Mach V Commander Helmet incorporates the safety performance features motorsports riders have come to expect from 509, an impact-resistant visor, controllable chase light, Fidlock Magnetic Chinstrap, and excellent moisture control with the patent-pending Venturi Venting System.

The Mach V Commander Helmet with Cardo Communications System is available for purchase on Ride 509 and at authorized 509 retailers nationwide.

About Cardo Systems

Cardo Systems provides cutting-edge communication devices and application services for power sports and outdoor enthusiasts. Cardo's devices and services promote riders' safety and enable motorcycle riders, off-road drivers, and adventure seekers to stay connected to their phones, music, and to each other. Cardo launched the world's first motorcycle Bluetooth-based wireless intercom headset in 2004.

About 509

Founded 20 years ago, the 509 story began as a snowmobile brand deep in the backcountry of the unforgiving Rocky Mountains. Those harsh environments inspired a journey of developing innovative and purpose-built riding gear, all while telling the story of the brand, our athletes, and the industry through our award-winning films and content. Today, 509 develops technical gear across the snowmobile, dirt bike, and motorcycle industries.

‍

Emergency physicians attending the ACEP23 conference in Philadelphia this week will be the first to see the new Clarius PAL HD3, a wireless handheld whole-body ultrasound scanner combining phased and line arrays on a single head. This device offers superior image quality and exceptional versatility for real-time imaging of both superficial and deep anatomy at the bedside, making it suitable for a wide range of clinical applications while improving workflow continuity. It's as compact as an iPhone and works seamlessly with iOS or Android devices, ensuring easy mobility from patient to patient. Clarius PAL HD3 has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and is available in the United States for 5395 USD plus 595 for the first year of membership.

"The Clarius PAL is a big breakthrough for Clarius and for clinical ultrasound in general. Integrating the phased and linear array means you only need one transducer for 95 to 99% of the studies at the bedside," says Dr. Tom Cook, an emergency physician and ultrasound educator who practices in South Carolina. "I work at a hospital with a big trauma center and being able to carry just one scanner to the bedside to get the best high-quality image to scan every part of the body in a few minutes is incredibly powerful. Everybody's very, very excited about it in my department."

With the broadest frequency range in a handheld ultrasound scanner, Clarius PAL HD3 is the only whole-body handheld scanner to deliver high-resolution images from the skin down to 40 cm of depth. Healthcare professionals can perform whole-body ultrasound exams without the need to swap devices or transport bulky systems between rooms, especially in critical care settings like the emergency room. Clarius PAL HD3 is the 11th wireless handheld ultrasound scanner in the Clarius specialty ultrasound lineup.

"The best thing about the Clarius PAL is it really does everything I need on a shift," says Dr. Oron Frenkel, an emergency physician who practices in the United States and Canada. "I don't ever have to reach for the cart to augment my practice. There is no situation that I can imagine where the scanner wouldn't be able to deliver what I need, either on the same patient, if I need to scan different parts of them during a single presentation, or going from bed to bed during a shift."

Related: Exo Iris: New Handheld AI-Powered Ultrasound System

Clarius ultrasound scanners are designed with 192 piezoelectric crystals and are widely known to deliver superior image quality.1 While most handheld scanners feature only 1 to 2 beamformers, Clarius uses the same advanced 8-beamformer processing technology used by higher-end traditional systems. This delivers up to 8 times the speed and performance of other handhelds for clear and detailed imaging to support precise and rapid assessments, ensuring accurate and timely care for patients.

About Clarius Mobile Health

Clarius is on a mission to make accurate, easy-to-use, and affordable ultrasound tools available to all medical professionals in every specialty. With decades of experience in medical imaging, the team knows that great ultrasound imaging improves confidence and patient care. Today, Clarius handheld wireless ultrasound scanners connect to iOS and Android devices, delivering high-resolution ultrasound images traditionally only available with bulkier, high-end systems at a fraction of the cost.

Home-use medical device manufacturer Hexainnoheal has been gaining recognition for its pain therapy products. Hexainnoheal manufactures healthcare devices using Low-Level Lasers and LED lighting. Its primary product line-up includes PainQ for pain management and CobiQ for rhinitis management. Hexainnoheal also focuses on developing a new product called Flexible PainQ.

Established in 2019, Hexainnoheal has been developing and supplying personal medical devices to the market using Low-Level Lasers, LED lighting, and electric current. PainQ, its representative device, is a home-use healthcare device for pain therapy that can effectively manage pain by combining Low-Level Lasers, LED lighting, and low-frequency stimulation functions. VCSEL laser light of 940nm (42 rays), 850nm (42 rays), and LED light of 642nm (42 rays) penetrate into the skin tissue and provide intensive care to the painful area. With an adjustable intensity range from level 0 to level 5, PainQ's low-frequency stimulation feature can be customized to the user's preferences. Due to its portable size and lightweight, users can wear PainQ as a belt to treat their pain in various areas, including the shoulders, wrists, and waist.

Hexainnoheal's CobiQ is a home-use health device for managing rhinitis. It delivers near-infrared light sources of 2 wavelengths into the nasal cavity and treats rhinitis by regenerating cells in the inflamed area. Hexainnoheal has extensive global marketing plans for CobiQ to enter its overseas export target markets, particularly North America and Europe. Since its launching this July on Amazon, CobiQ has been gaining momentum in global sales, receiving positive feedback from U.S. consumers.

Related: Revolutionary Wearable for Lower Back Pain

The CEO of Hexainnoheal shared, "We are constantly communicating with our customers and making continuous efforts to improve existing devices and develop new products," and introduced Flexible PainQ, which is under development process to remedy the shortcomings of the existing PainQ. Unlike the existing PainQ, Flexible PainQ can bend freely and is expected to be more effective in relieving pain in smaller areas like wrists

QuickSee Free, a new handheld wavefront aberrometry-powered autorefractor from PlenOptika, was named winner in the Material & Equipment category of the 30th SILMO D'Or awards in Paris on Saturday, September 30.

"This is a reward for a lot of innovation and work," said Rodolphe Tessé, President of Saargos, PlenOptika's distribution partner in France. "PlenOptika shares our values to bring better vision to people through technology."

QuickSee Free is PlenOptika's new medical device designed to make accurate objective refraction measurements— critical for accurate eyeglass and contact lens prescriptions—more accessible. "We designed QuickSee Free to help you, the opticians, optometrists, and ophthalmologists, improve your care for your patients and customers in your stores, hospitals, and clinics," said Shivang Dave, PlenOptika CEO, upon receiving the award."But also so you can transform how you reach people who might be not able to reach you. We're hoping this helps you continue to reach everyone in the world."

The SILMO D'Or Prizes are given each year at the SILMO International Optics and Eyewear exhibition, which is attended by more than 34,000 people. The prize recognizes the excellence, creativity, and innovation of manufacturers and brands from all around the world. In addition to the equipment category, prizes are given for lenses, children's eyewear, eyewear technology innovation, sunglasses brands and designers, eyewear frame brands and designers, and sport and protective eyewear.

"This is such an amazing event," said Dave. "We're honored to be a part of the innovation exhibited here."

Uncorrected refractive error, which can be treated with expensive eyeglasses, affects about 33 million people in the United States, and 1.1 billion people globally. PlenOptika designs technologies that replace outmoded legacy technology and address the critical shortage of trained professionals to meet the exam demand. QuickSee Free's accuracy and ease of use, enable task-shifting to trained operators, expanding workforce capacity, enabling new care modes in private practice and large-scale clinicalenterprises as well as in community and global health initiatives.

Related: Smart Contact Lens Powered by Salt Water

The technology development for QuickSee Free was supported in part by a grant from the NASA-supported Translational Research Institute for Space Health (TRISH), which leads a national effort to translate cutting-edge emerging terrestrial biomedical research and technology development into applied space flight human risk mitigation strategies for human exploration missions.

About PlenOptika

PlenOptika technologies enable new care modes that overcome the limitations of legacy care delivery models and equipment to help overcome the global burden of poor vision. With our flagship device QuickSee Free, vision professionals, NGOs, and governments experience new levels of flexibility and impact from the exam room to the showroom and beyond.

‍

FUJIFILM announced the launch of “INSTAX Pal™” on October 5th, 2023. It is a palm-top size camera to join the INSTAX series of instant cameras, allowing users to take photos anytime and anywhere. It will be available in five colors to suit different lifestyles, broadening the scope of shooting situations and experiences.

The toy-like camera features a 4.9-megapixel, 1/5-inch-typeCMOS sensor with a primary color filter, offers auto shutter speeds between 1/4to 1/8000 seconds, has ISO100 to 1,600 light sensitivity, sports a F2.2wide-angle lens, and its Li-ion battery is topped up over USB-C.

Released on the same day, silicone cases with strap carabiners in matching colors to INSTAX Pal, and the “Soft Lavender” mini-format film in purple, combining flamboyance with elegance, the company said in a press release.

The INSTAX instant photo system marks its 25th anniversary this year since its original launch in 1998. The system evolved with time, embracing trends and new technologies, to expand its lineup from analog instant cameras to hybrid instant cameras and smartphone printers. The INSTAX series offers diverse ways of enjoying photography to broaden its user base covering young people and middle-aged groups.

The new INSTAX Pal is INSTAX series’ first model specializing in taking pictures. Removal of the printing function has made it possible to reduce the size to a palm-top level for even greater walk-around capacity.

Related: The World’s Smallest Action Camera

The INSTAX Pal features a variety of functions to facilitate shooting situations and photographic experiences. The Standard mode, activated by pressing the shutter button on the rear panel, takes advantage of the wide-angle lens to shoot from an elevated position or at a sharp angle, difficult to achieve with smartphones, using just one hand to capture a dynamic image that brings in more of the background. The Remote mode connects the camera to a smartphone installed with a dedicated app via Bluetooth so that pictures can be checked on the smartphone as they are taken. The Interval mode takes photos continuously at a three-second interval. These features set this camera apart from smartphones with unique shooting experiences. The INSTAX Pal can also establish a Bluetooth connection with the INSTAX Link series of smartphone printers to produce INSTAX prints out of images taken with it.

Fujifilm will continue to expand the world of the “INSTAX” instant photo system that allows people to enjoy on-the-spot photo printing.

The majority of people have probably forgotten about PC manufacturers' efforts to give premium mobile VR in backpacks, but Zotac persisted in the concept. The fourth-generation VR Go system's recent release indicates the device has at least found a market.

Some regions now sell Zotac's VR Go 4.0 backpack PC, which the company first unveiled at Computex last year. While pricing and availability information hasn't yet surfaced in the US, UK dealers are now offering one of two SKUs for £3,699, or about $4,688, without the headset (link may be restricted for non-EU IP addresses).

The GPU is the only distinction between the new models. Both VR Go 4.0 SKUs switched to professional Ampere cards, the A2000 and A4500, representing a shift away from gamers and toward developers and other enterprise users. The previous VR Go 3.0 featured an Nvidia GeForce RTX 2070, reports TechSpot.

In addition, compared to the previous generation, there have been considerable improvements to the CPU, storage, and connection. The latest offering from Zotac has more USB 3.0 ports, Windows 11 Pro, an Intel Corei7-11800H processor, and a 512GB NVMe SSD (whose PCIe generation is unknown). Users can upgrade the DDR4 memory from the factory-set 16GB to 32GB and add more SATA-based storage.

Users shouldn't anticipate an exceptionally long battery life because the hardware is relatively high-end by most standards, especially for a mobile machine. The two provided batteries, which are hot-swappable and upgradeable, only give you about 50 minutes of playtime, as you might expect. The device, like other backpack PCs, may be taken from its straps and operated on a desk like a standard mini desktop tower.

Related: Virtuix Announces 'Omni One' VR Treadmill Release Date

During the initial surge in enthusiasm for VR and AR in the middle of the 2010s, Zotac began to release backpack PCs for mobile VR gaming alongside other firms like HP and MSI. The VR Go series from Zotac may have found a steady professional user base, but their exorbitant prices on top of the flagship headsets prevented them from being widely adopted.

Furthermore, the basic concept isn't all that unlike the experience Apple is attempting to deliver with its impending Vision Pro. However, the so-called "Spatial Computer" from Cupertino Giant will be smaller hardware that prioritizes AR over VR. However, it will still cost several thousand dollars and require a user-strapped external battery, likely posing the same challenges as the older backpack PCs until Apple's reputation and software ecosystem set it apart.

Exo (pronounced “echo”), a medical imaging software and device company, today unveiled a category-redefining handheld ultrasound device, Exo Iris™, to put high-performance medical imaging into the hands—and pockets—of every caregiver. Built on Exo’s advanced silicon technology, Exo Iris delivers versatile imaging performance for point-of-care ultrasound (POCUS)at a fraction of the size and cost of cart-based systems. Exo Iris is the latest addition to Exo’s ecosystem, which combines imaging, workflow software, and artificial intelligence (AI) to enable POCUS adoption at a system-wide scale. Exo Iris gives caregivers—including physicians, nurses, EMTs, and clinicians in emergency, acute care, outpatient, and at-home settings—a window into the human body for immediate answers at the point of care.

“Iris represents a new era of ultrasound,” said Sandeep Akkaraju, CEO and Co-Founder of Exo. “It’s built to perform as easily as taking an image with a smartphone. For caregivers who’ve bemoaned out-of-touch medical technology, you’ve been heard. This device is meant for you and everyone in healthcare—it will save lives, improve patient care, and lower costs. A testament to the transformative power of great design, Iris is the first of many innovations to come that will redefine the medical imaging space. We’re just getting started.”

Exo Iris is Designed for Simplicity and Immediate Answers

Designed around the caregiver, Exo Iris blends a simple user experience with powerful, real-time AI to enable even novice users to get instant answers at their fingertips. The company’s patented Sweep AI™ technology automatically acquires images with a sweep of the caregiver’s wrist, reducing operator dependence and bias to ensure consistent and accurate imaging, the company said in a press release.

Exo Iris comes equipped with Exo’s Bladder AI solution to help caregivers determine bladder volume in seconds. Exo has a suite of additional AI solutions coming soon, including FDA 510k-pending advanced Cardiac and Lung AI suites that provide real-time guidance and answers for caregivers to quickly and accurately diagnose, triage, and monitor heart and pulmonary conditions.

Exo Iris Delivers Point-of-Care Answers with Breakthrough Technology

Exo Iris is powered by Exo’s patented pMUT-based technology that blends the imaging excellence of piezoelectric crystals with silicon’s affordability. Exo’s silicon architecture allows for rapid imaging quality evolution and delivers real-time AI capabilities where every frame can be analyzed to guide the user to an immediate answer.

With this industry-first technology, Exo Iris delivers unparalleled sensitivity for seeing deeper into the body or tracking fine structures, enabling caregivers to scan all major organs and guide IVs and line procedures. In addition, caregivers have access to industry-leading features like ultra-wide field of view for imaging up to 150 degrees, allowing them to capture an entire liver or full-body fetus in a single view.

Exo Iris Easily Integrates with Any Healthcare IT System

Hospitals can easily connect Exo Iris to existing healthcare IT systems for compliance and storage, whether it be their PACS or VNA. They can also store exams on Exo’s secure cloud environment. Additionally, Exo Iris can functions without an internet connection, making it essential for caregivers in rural settings and in mobile response. Exo Iris comes equipped with Exo’s point-of-care ultrasound workflow solution, Exo Works™, to seamlessly document and review exams in seconds from anywhere. This combination blends an entire medical imaging ecosystem to perform flawlessly across hospitals, clinics, and at home, making communication across all spectrums of care possible. With Exo enabling system-wide adoption, health organizations finally have an answer for enterprise-level POCUS investment.

Exo Iris’ platform meets the highest bar for patient data security. It is HITRUST, HIPAA, SOC2 Type II compliant, and ISO 27001 certified. IT departments can rest assured of data protection and regulatory compliance.

Related: Konica Minolta Launches a New Wireless Handheld Ultrasound

Exo’s Ecosystem Will Create New Care Pathways

Exo Iris is another giant step towards Exo’s mission of bringing medical imaging everywhere through its simple and accessible ecosystem that delivers immediate answers at the point of care. Exo’s imaging platform enables caregivers to retrieve quick, accurate, and affordable imaging in any setting with Exo Iris, spend less time on administrative work and more time on delivering care with Exo Works, and easily acquire consistent and accurate images with real-time AI.

Price and Availability

Exo Iris is available for sale in the U.S. starting at an affordable price of $3,500.

About Exo

Exo is a medical imaging software and device company. Exo believes everyone around the world should have access to high-quality, affordable, and easy-to-use medical imaging. The company is on a mission to modernize medical imaging through its high-performance ultrasound platform and artificial intelligence. Exo’s goal is to enable healthcare professionals to make critical, real-time decisions that ultimately improve patient outcomes.

Onward Medical announced that it completed the first-in-human implant of its ARC-IM stimulator for restoring upper extremity function.

Eindhoven, The Netherlands-based Onward designed the stimulator to restore function after spinal cord injury (SCI). The patient also received a wireless brain-computer interface (BCI) for initiating thought-driven movement when paired with ARC-IM.

ONWARD ARC-IM delivers targeted, programmed ARC-IM Therapy to the spinal cord to restore movement and other functions after spinal cord injury. ARC-IM Therapy has been applied across multiple clinical feasibility studies to restore mobility and stabilize blood pressure after SCI. For the first time, ARC-IM Therapy has now also been used to restore upper extremity movement and function.

Two procedures were performed last month by neurosurgeon Jocelyne Bloch, MD, at Centre Hospitalier Universitaire Vaudois (CHUV) in Lausanne, Switzerland. The ARC-IM implant procedure took place on August 14, 2023, and nine days later the BCI WIMAGINE® from CEA-Clinatec was implanted.

Working in concert with ARC-IM, the BCI is engineered to capture the intention of a paralyzed individual to move their upper extremities and uses artificial intelligence to decode those thoughts. ARC-IM then converts the decoded information into ARC-IM Therapy - precise stimulation of the spinal cord - resulting in thought-driven movement.

“The implant procedures involving the ONWARD ARC-IM and Clinatec BCI went smoothly,” said Dr. Jocelyne Bloch. “We are now working with the patient to use this cutting-edge innovation to recover movement of his arms, hands, and fingers. We look forward to sharing more information in due course.”

This latest breakthrough is part of an ongoing clinical study investigating the safety and effectiveness of thought-initiated spinal cord stimulation after SCI. It builds on the ONWARD announcement from May 2023 that pairing its ARC Therapy with a BCI implant resulted in an individual gaining augmented control over the movement of his paralyzed legs. The study is supported by a grant from the European Innovation Council (Reverse Paralysis project) and is coordinated by NeuroRestore co-Directors – Professor GrégoireCourtine and Dr. Jocelyne Bloch – as well as Guillaume Charvet, head of the Medical Device Development Lab at CEA-Clinatec.

Related: Cala Health's Neurostimulation System Treats Parkinson's

“This is another impressive piece of research from our partners at NeuroRestore. We are excited to learn how ARC-IM Therapy may restore upper extremity function after SCI, and we are eager to see how the addition of a BCI might augment our therapy,” said Dave Marver, CEO of ONWARD.“Congratulations to the teams at EPFL, CHUV, and CEA-Clinatec for this breakthrough. We feel privileged that our technology is part of this research.”

The Company expects to share more information about this pioneering research in the coming months, concurrent with a peer-reviewed publication describing the procedure and results.

About ONWARD Medical

ONWARD is a medical technology company creating therapies to restore movement, function, and independence in people with spinal cord injury(SCI) and movement disabilities. Building on more than a decade of science and preclinical research conducted at leading neuroscience laboratories, the Company has received nine Breakthrough Device Designations from the US Food and Drug Administration for its ARC Therapy platform.

‍

LAWK ONE takes augmented reality to new heights, revolutionizing the way outdoor sports are experienced. With its advanced AR capabilities, which are based on vision systems and heads-up displays, LAWK overlays virtual information onto the real world through its intelligent display screen.

Users can access real-time data such as speed, distance, and time, and even receive navigation guidance, route planning, take pictures, play music, and ask AI assistants for help.

·       Sports Data Recording and Export: LAWK ONE provides users with a comprehensive sports data display. Speed, distance, time, and other vital metrics are seamlessly integrated into the user's field of vision, allowing for real-time monitoring and analysis. What sets it apart is the seamless data export functionality, empowering users to share their achievements effortlessly.

·       Real-Time Navigation: LAWK ONE eliminates the need to glance at your phone for navigation, enhancing safety during activities like cycling. The real-time navigation feature keeps directions right before your eyes.

·       4K HD Video Shooting: Capturing the most thrilling moments of outdoor adventures is made effortless with LAWK ONE's high-quality camera. Capture breathtaking moments and create first-person perspective videos with ease.

·       Music playback: The glasses' built-in music player adds an extra layer of enjoyment, allowing users to listen to their favorite tunes while immersing themselves in the great outdoors.

·       AI Assistant Capabilities: LAWK ONE boasts AI assistant functionality, harnessing the power of AI for instant assistance. Users can ask questions on the go, providing personalized recommendations, weather updates, and other useful information, all at the user's command.

Related: This AR Attachment Lets You Access Android TV Anywhere

These features not only enhance the safety and convenience during outdoor activities but also add an element of excitement and challenge. Crafted with the utmost attention to detail, LAWK ONE combines style and functionality. The glasses are designed to be lightweight, comfortable, and durable, making them the perfect companion for any outdoor adventure. With its sleek and modern design, LAWK ONE sets a new standard for AR sports glasses.

About LAWK

LAWK, a tech startup backed by ByteDance investments, is blazing a trail in the tech industry with cutting-edge AI+AR eyewear technology. Positioned as a practical multi-scenario AI+AR eyewear company, LAWK envisions a future where its innovations transform various user experiences. LAWK is poised to continue its ascent as a leading player in the AI+AR eyewear industry, offering practical solutions for tech-savvy adventurers.

In a world characterized by rapid technological advancements, health monitoring has taken a giant leap forward with the groundbreaking innovation by LIFEPLUS with its flagship product LIFELEAF. This month, we're excited to shine a spotlight on this remarkable creation that is changing the way we track and take control of our health. LIFELEAF is not just another health and fitness tracker; it is an adaptive self-learning solution designed to empower individuals and their loved ones to make informed decisions about their health and well-being.

Addressing a Real Problem

The journey of LIFELEAF began with a personal frustration. One of the co-founders, deeply concerned about the lack of timely vital health information available for his aging relatives living far away, embarked on a mission to bridge the gap. He realized that having real-time insights into daily vital health statistics could significantly improve healthcare outcomes for his loved ones. This realization marked the birth of LIFELEAF, an ingenious solution that combines innovation with empathy.

A Revolutionary Approach to Health Tracking

LIFELEAF distinguishes itself from conventional health and fitness trackers in several ways. Equipped with a network of non-invasive sensors, it continuously monitors an array of vital statistics. This real-time data is streamed to a HIPAA-compliant cloud storage platform, where sophisticated AI algorithms work their magic to generate actionable insights. These insights are then transmitted to the user's mobile application in the form of alerts and notifications.

One of the most remarkable aspects of LIFELEAF is its focus on creating a community of care. By sharing your health data with a selected community, which can include family, friends, and healthcare providers, you can collaborate on ensuring your well-being. Accessible through a personal web portal, this data-sharing feature makes it easy for your support system to keep an eye on your health and provide help when needed.

Key Features: A Comprehensive Health Picture

LIFELEAF's extensive set of features is designed to provide a holistic view of your health:

Oxygen Saturation: By monitoring your blood oxygen levels in tandem with blood sugar levels, you can ensure the health of your cells.

Heart Rate and Rhythm: Track your heart's function and rhythm with continuous measurements, aiming for a better-resting heart rate.

Respiration: Every breath matters, and by measuring your respiration rate, you can assess overall heart health and detect short-term blood sugar complications.

Steps: Count your steps as motivation to reach new levels, as physical activity supports every physiological system.

Meals: Health begins with nutrition, and LIFELEAF lets you see how your meal choices affect your overall health trends through easy meal tracking.

Data Sharing: LIFELEAF allows you to share your data with your doctor, family, or caregivers in a HIPAA-compliant format, creating a collaborative approach to health management.

Alerts: Instant alerts notify you whenever your health levels fall outside specified ranges. Directional arrows and color coding provide extra context to help you quickly understand each alert.

Always-On Monitoring: LIFELEAF works round the clock, automatically measuring and tracking your metrics throughout the day, without inconveniencing you.

Motivation: Monitor your progress and witness the true impact of your habits on your health, providing you with the motivation to make positive changes.

Comprehensive Web Portal: Access a detailed view of your data, and make it easy for loved ones to log in and monitor your health from anywhere.

‍

Product Details

The user interface of LIFELEAF is designed to be simple and easy to understand, enabling users to visualize their data and interpret health implications at a level that suits their needs.

Cutting-edge Sensors: LIFELEAF utilizes innovative optical sensors that measure key health markers with groundbreaking technology that is safe, accurate, and completely non-invasive.

Intelligent Data: The more you wear LIFELEAF, the smarter it becomes, helping you see and understand your health in new and meaningful ways.

Comfortable Design: The LIFELEAF strap and body are thoughtfully designed to be worn all the time, offering breathability and comfort without interfering with your daily activities.

In conclusion, LIFELEAF is more than a health and fitness tracker; it's a paradigm shift in the way we approach health and wellness. It empowers individuals to take charge of their well-being while fostering a community of care. With its non-invasive sensors, AI-driven insights, and real-time monitoring, LIFELEAF is setting a new standard in health tracking and management, making it our Innovation of the Month. Whether you're focused on managing chronic conditions or simply aiming for a healthier lifestyle, LIFELEAF provides the tools and insights you need to make informed decisions about your health.

‍

‍

‍

‍

HoneyNaps, the leading-edge AI-based sleep disorder diagnosis software company, has announced that its SOMNUM AI sleep disease analysis algorithm has been approved by the U.S. Food and Drug Administration(FDA).

AI and medical devices are a sought-after combination, but the FDA has granted only two approvals for sleep disease diagnosis solutions by U.S. companies. HoneyNaps is the first Korean company to identify its FDA approval as a demonstration of its technology's capabilities. By integrating the latest AI research trends with diagnostic algorithms based on multi-channel/time series sleep biosignal data rather than by reading video images, HoneyNaps is paving the way for the future of AI in healthcare.

Sleep biosignals tend to include electroencephalograms, electrooculograms, chin and leg electromyograms, electrocardiograms, respiratory airflow and effort, oxygen saturation, posture, and snoring, and these are monitored continuously during sleep for assessing sleep status and sleep disorder diagnosis via polysomnography.

The process of reading these results can take up to three to four hours by skilled personnel. AI reading systems have become highly researched to overcome staffing and time obstacles. The complex and heterogeneous nature of biosignals lends to a high level of difficulty when it comes to improving such AI systems to a level that yields the same output as a human.

HoneyNaps' AI solution for diagnosing sleep disorders,' SOMNUM,' transcends conventional video image reading systems for biosignals. It leverages deep learning-based AI to perform real-time analysis of vast volumes of multi-channel/time series biosignals, setting a new standard for accuracy and transparency in the field. SOMNUM's development is underpinned by the pioneeringeXplainable Medical AI (XAI) technology.

Professor Ji Ho Choi, Head of the Centre for Sleep Medicine at Soonchunhyang University Bucheon Hospital, said, "Like the AlphaGocase, which defeated humanity, this FDA approval is a very important event and a turning point in the field of sleep medicine in Korea. In the future, AI reading technology for biosignals is expected to play a very important role, similar to AI autonomous driving technology in cars. Furthermore, with the continuous improvement of biosignals AI reading technology, it will be possible to detect or predict some cardiovascular, neurological, and muscular diseases beyond the diagnosis of sleep disorders."

Numerous studies using SOMNUM have been presented at international conferences as part of presentations such as "A robust hybrid algorithm for automatic respiratory events scoring in adults" at Sleep 2023, and "Validation study of neural network algorithm for automated sleep stage scoring" at World Sleep 2019, held by the World Sleep Society (WSS). In addition, the study "Validation study on automated sleep stage scoring using a deep learning algorithm" was published in an SCIE journal.

Related: FDA Greenlight Given To Sleep Monitoring Device

Tae Kyoung Ha, General Representative Director at HoneyNaps, said, "The FDA has recently strengthened its review of AI-based medical devices, and we passed the review in three years by conducting clinical trials with 400 subjects including U.S. citizens directly, rather than through an agency, from the validation stage.

This is an opportunity for us to further enhance our technology, such as adding diagnostic functions for cardiovascular and neuromuscular diseases, and to accelerate our expansion into the global market."

About HoneyNaps

HoneyNaps develops essential technologies for sleep disease diagnosis, biosignal monitoring, assessments, and treatments including the company's groundbreaking tech SOMNUM.

Pain Relief Technology, LLC, a newcomer to the wellness industry, has unveiled the Bax-si, its flagship, eponymous device, designed to provide non-invasive pain relief for those who suffer from lower back discomfort. Their invention comes at a time when back pain relief products are seeing a surge in demand, with many adults and seniors seeking efficient, home-based solutions to their back muscle inflammation and sacroiliac joint-related issues.

The unique selling point of the Bax-si is its focus on opening the sacroiliac joint, thus relieving pressure and discomfort in the lower back region. As per the company's testimonials, no other device in the market today offers this unique method of offering sacroiliac joint pain relief. The Bax-si is an FSA/HSA eligible product.

A spokesperson for the company has stated "We identified that while there are numerous lower back pain relief products available, none specifically target the sacroiliac joint - a key pain point for many."

The Bax-si offers a customizable approach, with the product including two silicone gel wave heads – a softer green one and a firmer blue one – catering to various intensity needs, allowing users to tailor treatment to suit their comfort levels.

The device is compact and portable, coming with a travel bag, allowing users to continue their lower back pain treatment at home or on the go. The product also touts ease of use and hygienic maintenance – with a simple switch-out design – making it a convenient option for a busy lifestyle.

Maximizing Mobility and Wellness with Bax-si

The uniqueness of Bax-si lies in its design. Its underlying technology and its thought process help set it apart. Bax-si works to address pain at its source, targeting the sacroiliac joint for enhanced relief and movement.

Related: Dissolving Implantable Device Relieves Pain Without Drugs.

Reviews for the Bax-si include statements like "Significantly reduced my lower back pain" and "immediate pain-relieving and performance enhancing results," showing the positive impression that it's made on its customers in a short time.

Bax-si's Commitment to their Customers

Given the rising global statistics of individuals seeking back pain treatment devices in the wake of the post-COVID work-from-home revolution, there's an imminent need for innovative solutions. Bax-si, with its forward-thinking design, addresses this gap and establishes a new benchmark for products in this domain.

With rave reviews, it's clear that the Bax-si is aiming to redefine the landscape of non-invasive pain relief products, by not only promising relief but also guaranteeing a heightened sense of well-being. By allowing users to rediscover their most dynamic, athletic selves without the daily grind causing too much discomfort, the Bax-si is likely to be a common feature in many households soon.

About Pain Relief Technology

Established in 2023, Pain Relief Technology LLC emerged with a vision to revolutionize the health and wellness sector, specifically focusing on non-invasive pain relief that users can experience from the comfort of their own homes. Through collaborations with its own team of researchers, healthcare experts, and engineers, the brand is on a mission to push the envelope. As the only device in the world targeting the sacroiliac joint with precision and effectiveness, Bax-si is an intriguing option for those who have been experimenting with different methods of treatment.

During the recently completed HUAWEI CONNECT 2023 event, Huawei, a leading global technology company, announced its Digital Medical The solution is poised to revolutionize the healthcare sector by hastening the implementation of intelligent healthcare practices.

Zhao Yixin, General Manager of the Education and Healthcare Industries of the Global Public Sector of Huawei, delivered a speech titled "Intelligence Reconstructs Future Healthcare, Innovation Strengthens Digital Health". Focusing on healthcare intelligence, Huawei is committed to breaking digital boundaries and developing innovative all-scenario healthcare solutions to facilitate high-quality development of the healthcare industry.

Digital Medical Technology Facilitates Accurate and Efficient Healthcare

The Huawei Digital Medical Technology Solution builds a unified architecture based on cloud computing, big data, and AI that benefits medical imaging services in hospitals around the world. It has five major features: hospital-wide data convergence, multi-protocol and copy-free, lossless compression, SmartCache 2.0 AI prefetch, and video-network collaboration. Over 1000 images and pathology slices can be viewed in seconds, saving 30% of storage space and 70% of equipment room space. It also helps deliver accurate, efficient, and consistent image reading and diagnosis services.

Related: Evernorth Expands Its Digital Health Formulary

This solution has been successfully implemented in the regional medical imaging platform project of the Longgang District Health Bureau, Shenzhen. Thanks to this platform, 12 hospitals in Longgang District have access to interconnection and can share medical image data. They have one-click access to imaging reports, and benefit from mutual recognition of examination results across hospitals. Data is fully utilized to serve patients more efficiently, and regional imaging resources are distributed in a more reasonable way.

Huawei continues to step up its innovation and investment in the field of intelligent healthcare. Up to now, Huawei has served upwards of 5,000 hospitals and research institutions in over 90 countries and regions and has more than 3300 ecosystem partners.

ELEHEAR, an innovator in AI-powered hearing aids and audio solutions, introduced its first OTC hearing aid devices: the ELEHEAR Alpha and ELEHEAR Alpha Pro. These hearing aids by ELEHEAR utilize accumulated knowledge from past algorithms and sound technologies. The ELEHEAR technical team has harnessed this expertise to create a new application that incorporates AI noise reduction and speech extraction. It learns from users' daily actions to predict and minimize the impact of noise in typical audio environments such as homes, offices, public transit, busy streets, and restaurants. This hearing aid offers an exceptional auditory experience at an incredibly affordable price point, specifically designed for individuals with hearing loss.

"We want to improve the lives of individuals with hearing loss by bringing next-generation, enterprise-level technology built on artificial intelligence to the OTC market. We empower people with accessible, high-quality hearing enhancement solutions that go beyond just restoring hearing - we strive to elevate the auditory experience to new heights," remarked the ELEHEAR team.

The ELEHEAR team believes that a good hearing aid should return to the essence of a product that works well. These three key features are vital for a good hearing aid:

1.     An elegantly compact and featherweight design for enduring comfort.

2.     Exquisite sound quality, embracing advanced noise-reduction prowess, generous amplification, and masterful feedback orchestration.

3.     Extended battery longevity, assuring an uninterrupted symphony of use throughout the day.

However, achieving all three of these points simultaneously in a single hearing aid is challenging, as they inherently conflict with each other. To make a device smaller, there may be compromises in terms of battery life and noise reduction. Most hearing aids on the market typically excel in one or two of these aspects, but only a product that excels in all three can be considered outstanding. ELEHEAR Alpha Pro accomplishes this without sacrificing any of these features.

Related: Study: Apple AirPods Pro Can Double As Hearing Aids

We can see that ELEHEAR Alpha Pro includes many features of a high-quality hearing aid, including the following:

·       Comfort Redefined: Comfort is not just an add-on; it's a core feature of the Alpha Pro. The device's sleek and feather-light, with a 3.8g weight design guarantees a seamless fit, allowing users to wear it throughout the day without experiencing any discomfort.

·       AI Noise Reduction: ELEHEAR's AI technology excels in distinguishing human voices from background noise, preserving the natural clarity of the listening experience. Unlike conventional methods that apply noise reduction to both voices and environmental sounds, our approach minimizes distortion while enhancing voice quality and speech clarity. In a deep learning process, the device first picks up the user's audio environment and then trains the AI via the app and cloud processing, and then sends those customized environmental parameters back to be run on the device.

·       Crystal Clear Sound: 32kHz Ultra HD Speech Signal Processing delivers unparalleled natural sound quality in a compact design.

·       20-hour battery life: The hearing aid features a rechargeable lithium battery that supports wireless charging. With one charge, it runs for 20 hours, ensuring an entire day of uninterrupted listening.

·       Bluetooth Streaming: Seamless transition between Hearing Aid and Bluetooth Headset Modes, lets users enjoy both calls and music anytime.

·       In-App Remote Adjustment: The user-friendly companion app enhances users' hearing experience and lets people enjoy personalized audio tailoring for an immersive journey.

·       Feedback Control: VoClear AI predicts possible feedback sources and neutralizes them within milliseconds, delivering a clear and comfortable hearing experience.

·       Affordable Excellence: In a market where quality often comes at a premium, the Alpha Pro breaks the mold by offering top-tier features at an affordable price point. This makes advanced hearing technology accessible to a wider audience, fulfilling ELEHEAR's mission to enhance lives through innovation.

Price and Availability

Elehear Alpha available with a limited-time offer of $399(with a retail price of $899) during the product launch period until October 31, 2023. For users seeking advanced features like full Bluetooth integration and more powerful noise reduction, audio environment analysis, and feedback control, ELEHEAR Alpha Pro is available at $499 (with a retail price of $999).ELEHEAR offers a 45-day money-back guarantee with a 1-year warranty. These generous pricing strategies ensure that users can access high-quality hearing aids at reasonable prices. US customers can purchase the Alpha and Alpha Pro via the ELEHEAR website starting September 25th at 9 AM EDT.

About ELEHEAR

Founded in 2017, ELEHEAR pushes the boundaries of hearing enhancement by creating technologies that empower people through excellent hearing. The company's breakthrough deep learning AI algorithm—VocPlus—rooted in Computational Auditory Scene Analysis ("CASA") and Deep Learning("DL")—has been installed in over 200 million consumer devices worldwide.

1MORE, a leading audio company dedicated to delivering superior sound quality, announced the launch of its groundbreaking 1MORE Fit Open Earbuds S50 and 1MORE Fit SE Open Earbuds S30 with open-air design. These cutting-edge audio accessories are meticulously engineered to enhance the auditory experience for athletes and fitness enthusiasts, revolutionizing the way they engage with their favorite tunes while staying active.

1MORE Fit Open Earbuds S50:  Open Ear, HiFi Music

The 1MORE S50 redefines sports audio with a host of groundbreaking features. The integration of the 1MORE PurePower Driver with its strong magnetic design results in a remarkable 40% increase in driving force, ensuring an unparalleled auditory journey. The advanced DLC (Diamond-Like Carbon) diaphragm guarantees superior sound quality, while the collaboration with Sonarworks and the exclusive Sound ID feature brings a personalized sonic experience like never before, 1More said in a press release.

Grammy master-tuned sound elevates the listening experience with balanced acoustics and meticulous attention to detail. The revolutionary Open-Air Tech employs innovative Directional Sound Loops, enveloping the user in a captivating soundscape. The skin-friendly silicone material, coupled with the ergonomic ear hooks, guarantees ultimate comfort during extended wear.

Durability meets convenience with IPX7 sweat resistance, allowing users to push their limits without compromising the audio quality. The 1MORE S50 boasts an impressive 38-hour battery life and features a remarkable 5-minute quick charge that grants an additional 2 hours of playtime. Wireless charging via Qi-enabled technology ensures hassle-free recharging, and Bluetooth 5.3 technology establishes seamless connectivity.

1MORE Fit SE Open Earbuds S30: Boost Your Sports Mood

The 1MORE S30 redefines how athletes interact with audio during their workouts. These headphones are powered by a 14.2 mm Dynamic Driver featuring a DLC diaphragm, and offer unparalleled sound quality. The incorporation of the DBB Low-Frequency Enhancement Algorithm further enriches the audio experience.

The Innovation Open-Air Design of the 1MORE S30 embraces a novel approach to athletic audio, ensuring 10g of each earbud fits snugly and gently curves for optimal comfort. This design promotes situational awareness, enhancing safety during movement-intensive activities.

Related: Mymanu CLIK S Earbuds

With IPX5 sweat resistance, the 1MORE S30 stands up to rigorous workouts, while the 4-Mic Intelligent Noise Cancelling filters the environmental noise when you are on a call, keeping all the details of your voice. The 1MORE S30 boasts an impressive 30-hour battery life and utilizes Bluetooth 5.3 technology for seamless connectivity.

Both the 1MORE S50 and S30 sports headphones embody 1MORE'scommitment to delivering superior audio experiences, providing athletes with the perfect blend of innovation, comfort, and performance.

Price and Availability

The 1MORE S50 and S30 sports headphones will be available for purchase on Amazon for $119.99 and $59.99 Now.

ABOUT 1MORE

1MORE specializes in acoustic design and development, smart software, and wearable audio products. Born with a profound mission to deliver superior audio quality at consumer-friendly prices. Additionally, 1MORE's products have received multiple industry and design awards including prestigious CES Innovation awards, RedDot, iF Design awards, and other major industry accolades.

Leading MedTech company Stryker unveiled its next generation of minimally invasive surgical cameras: the 1788 platform. The fully enhanced camera is set to advance surgery across multiple specialties.

The all-in-one surgical camera platform offers a more vibrant image with balanced lighting, a wider color gamut, and a clearer delineation of fluorescence signals. The platform is designed for improved visualization of blood flow and critical anatomy and has the ability to visualize multiple optical imaging agents – when it matters most.

"When it comes to surgical outcomes, dependable imaging is one of the most critical factors. With the enhanced imaging capabilities of 1788, surgeons have a complete surgical camera technology that provides consistent and vivid imaging," said Dr. Matthew Albert, colon and rectal surgeon at Advent Health. "Patients deserve high-quality care, and we're thrilled that this solution allows our operating room teams to deliver just that."

The 1788 platform is compatible with the currently marketed imaging agents and adaptable to new agents and fluorescence modes as they become available, the company said in a press release.

The advances in this technology also enable a broader range of clinical applications and enhance additional specialties, including urology, neurology, and ear, nose, and throat.

"Stryker partnered with our surgeon users to design the 1788 platform to be a powerful partner in the OR and to enhance the surgical experience across specialties. This is another way in which Stryker is living up to its rich legacy of delivering the most innovative surgical technology to help surgeons support improved patient outcomes," said Andrés Rosales, vice president and general manager of Stryker's Endoscopy business unit.

Related: Johnson& Johnson Partners With Microsoft For Digital Surgery Solutions.

"The early feedback has been that the 1788 camera delivers better fluorescence imaging and an enhanced user experience, which is particularly helpful in those deep or highly complex cases when surgeons are working in tight cavities—such as sinus cases and pituitary resections," added Rosales.

"Clear visualization is a necessity when a patient's life is in your hands. It's important that surgeons can visualize perfusion and critical anatomy to make surgical decisions intraoperatively," said Dr. Albert.

Notable features of the 1788 platform include:

·       Wider color gamut for 62.5x more visible colors

·       Improved fluorescence imaging with better consistency

·       High dynamic range and new tone mode for more balanced lighting

·       Cleared to visualize CYTALUX, an imaging agent designed to illuminate lung and ovarian cancer intraoperatively

About Stryker

Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopedics, and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 130 million patients annually.

Beacon Biosignals announced the milestone achievement of FDA510(k) Clearance for its Dreem 3S, an advanced wearable headband with integrated machine learning algorithms to capture electroencephalogram (EEG)data from the brain to monitor sleep architecture and aid in the diagnosis of disturbed sleep. FDA Clearance marks it as equivalent to in-lab polysomnography for the assessment of sleep staging. The easy-to-use device makes it simple for patients to participate in clinically validated, EEG-based sleep monitoring at home, unlocking new insights into sleep physiology. Beacon Biosignals, a health technology company whose work focuses on accelerating the development of treatments for neurological, psychiatric, and sleep disorders, acquired the Research and Development business of Dreem in July 2023. The Dreem 3S provides the company yet another asset to provide rich datasets that deepen the understanding of brain activity during sleep.

Maurizio Fava MD, Psychiatrist-in-Chief at Massachusetts General Hospital and Beacon Scientific Advisory Board member commented on the Dreem 3S clearance, "It is very important patients suffering from disturbed nighttime sleep be accurately monitored in their natural settings. This new solution makes that possible and has the potential to help further research and therapeutic interventions within the field."

Sleep disorders affect millions of Americans, with strong links to underlying etiology in conditions ranging from major depressive disorder to neurodegenerative disease (Krystal, 2012). While often overlooked, disturbed nighttime sleep may play a significant role in patient-reported quality of life and daytime functioning in disorders associated with sleep comorbidities, such as atopic dermatitis or chronic pain (Bawany et al., 2021). Traditionally, capturing sleep endpoints in the development of novel therapies requires patients to spend nights in sleep laboratories, or rely on less-precise surrogate measures of sleep activity via wrist actigraphy, according to a press release.

The Dreem 3S medical device transforms this process. As the first dry-EEG medical device of its kind, it allows for convenient EEG data collection at home and provides automated sleep staging according to the American Academy of Sleep Medicine (AASM) classification. Patients use the device independently, from the comfort of their home. The Dreem 3S is designed to record for a duration of 24 hours, is equipped with 6 electrodes, and features an integrated accelerometer to measure head movement and body position while optimizing continuous high-quality data collection. A clinical usability study demonstrated that the Dreem 3S is both well-tolerated by users and produces clinical-grade data in the home environment. The Dreem 3S automated sleep staging algorithm performed as well or better than individual human experts as reported in the literature (Guillot et al, 2020; Rosenberg et al, 2013).

Jacob Donoghue MD PhD, CEO and co-founder of BeaconBiosignals, emphasized the impact of the technology in clinical trials, "Longitudinal EEG sleep data may be a powerful tool to gain clinical insight into a wide variety of neurological and psychiatric conditions. We are enabling high-fidelity, overnight brain activity to be efficiently collected in the patient's home, opening new doors for clinical trial endpoints."

Related: Tracking Sleep with a Self-Powering Smart Pillow

Alexander Chan PhD, Beacon's Vice President of Analytics and Machine Learning added, "The advanced machine learning algorithms of the Dreem 3S will be instrumental in reducing the human variability that is present within existing clinical workflows, allowing for more precise, accurate insights for driving forward therapy development for sleep and sleep-related disorders."

This milestone complements Beacon Biosignals' machine learning platform for EEG and PSG, enabling rapid analysis of large clinical neurophysiology datasets. Potential partners and clinical trial collaborators interested in exploring the possibilities for including the Dreem 3S in clinical trials in neurology, psychiatry, sleep medicine, and beyond should contact the company at https://beacon.bio/contact/.

About Beacon Biosignals

Beacon's machine learning platform for EEG enables and accelerates new treatments that transform the lives of patients with neurological, psychiatric, or sleep disorders. Through novel machine learning algorithms, EEG wearables, large Clinico-EEG RWE datasets, and advances in cloud-based scientific computing, Beacon Biosignals is changing the way patients are treated for disorders of the brain.

Optoma introduced the Optoma UHZ35ST, a short throw, laser true 4K UHD home entertainment and gaming projector following the popular UHD35STx. With its external power supply and various feature upgrades, the UHZ35ST offers more reliability, portability, and energy efficiency than its predecessors.

Featuring 3,500 lumens, a 500,000:1 contrast ratio, and a DuraCore laser light source, the Optoma UHZ35ST delivers high brightness, superior color performance, impressive installation flexibility, and a long life span of up to 30,000 hours in Eco Mode for maintenance-free operation. With the short throw lens, consumers can display up to 100-inch images from a few feet away from the screen, allowing for big-screen viewing and simple set-up in a variety of settings. The UHZ35ST also sports a compact design and is 34% smaller than the UHD35STx, making it the most compact projector in its class, says a press release.

Equipped with horizontal and vertical keystone, as well as 360° and portrait mode operation, the UHZ35ST guarantees flexible installation in virtually any orientation and location with its small, lightweight footprint. Designed with the environment in mind, the UHZ35ST's chassis is made up of 50% post-consumer recycled (PCR) materials to ensure environmental sustainability.

The UHZ35ST also delivers amazing input responses that are unrivaled in consumer projection today. With four times the standard refresh rate at 240Hz in 1080p and an ultra low-input lag of 4ms for PC gaming, the UHZ35ST gives hardcore gamers a competitive advantage with its crystal clear images at every point of action and smooth and responsive gaming experience.

"The new UHZ35ST offers all the top features that have made our popular UHD35STx a favorite, boasting an industry-leading low latency and flexible short throw performance," said Oliver Blundell, Product Manager at Optoma. "Paired with a new laser light source and more sustainable chassis, the UHZ35ST guarantees greater energy efficiency for elevated home entertainment and gaming experiences."

Read more: First Ever Portable Projector for Life Outdoors

Optoma UHZ35ST Key Features:

·       Resolution: 4K UHD (3840x1260)

·       Brightness: 3,500 lumens

·       Contrast ratio: 500,000:1

·       Throw ratio: 0.496:1

·       Light source: DuraCore laser light source with up to 30,000 hours of maintenance-free operation (in eco mode)

·       Built-in Enhanced Gaming Mode with 4ms response time in 1080p at 240Hz and 16.9ms response time in 4K at 60Hz

·       Flexible installation with 360° and portrait mode operation

·       I/Os: 2x HDMI 2.0 in, 3.5mm Audio out, USB-A power 1.5A, RS232, RJ45

Price and Availability

The Optoma UHZ35ST is available for purchase in the United States for an estimated street price of $3,299 in the United States and $4,499in Canada, CAD.

About Optoma Technology

Optoma combines cutting-edge technology and innovation to deliver remarkable visual display products designed to connect audiences with engaging video experiences. From the company's ProScene projectors to its Creative Touch interactive flat panel displays, Optoma's suite of products can meet the demands of nearly any professional environment, including conference rooms and classrooms, digital signage, corporate, houses of worship, retail, simulation environments, and control rooms. Optoma Technology is the U.S. headquarters for The Optoma Group, with continental headquarters also in Europe and Asia.